Related references
Note: Only part of the references are listed.Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies
Barnaby Young et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Immunological memories of the bone marrow
Hyun-Dong Chang et al.
IMMUNOLOGICAL REVIEWS (2018)
Generation of memory B cells and their reactivation
Takeshi Inoue et al.
IMMUNOLOGICAL REVIEWS (2018)
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
S. Sridhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Explanations for the high potency of HPV prophylactic vaccines
John Schiller et al.
VACCINE (2018)
Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
Mona Marin et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
US had record flu deaths last year, says CDC
Owen Dyer
BMJ-BRITISH MEDICAL JOURNAL (2018)
Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers
Nicole P. Lindsey et al.
JOURNAL OF TRAVEL MEDICINE (2018)
Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011-2012 Through 2014-2015
Jill M. Ferdinands et al.
CLINICAL INFECTIOUS DISEASES (2017)
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada
Danuta M. Skowronski et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Dengue vaccine safety signal: Immune enhancement, waning immunity, or chance occurrence?
Bradford D. Gessner et al.
VACCINE (2017)
Antibody persistence and evidence of immune memory at 5 years following administration of the 9-valent HPV vaccine
Ana Guevara et al.
VACCINE (2017)
Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform
John R. Gallagher et al.
VIROLOGY (2017)
Plasma cell survival in the absence of B cell memory
Erika Hammarlund et al.
NATURE COMMUNICATIONS (2017)
Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine
Pierre Van Damme et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection
R G Pebody et al.
Eurosurveillance (2017)
Germinal center enhancement by extended antigen availability
Kimberly M. Cirelli et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Characterization of the size distribution and aggregation of virus-like nanoparticles used as active ingredients of the HeberNasvac therapeutic vaccine against chronic hepatitis B
Matilde Lopez et al.
ADVANCES IN NATURAL SCIENCES-NANOSCIENCE AND NANOTECHNOLOGY (2017)
Plasma cell and memory B cell differentiation from the germinal center
Dan Suan et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
Vijay G. Bhoj et al.
BLOOD (2016)
Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis
Erika Hammarlund et al.
CLINICAL INFECTIOUS DISEASES (2016)
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
E. Kissling et al.
EUROSURVEILLANCE (2016)
Questions regarding the safety and duration of immunity following live yellow fever vaccination
Ian J. Amanna et al.
EXPERT REVIEW OF VACCINES (2016)
Temporal stability and molecular persistence of the bone marrow plasma cell antibody repertoire
Gabriel C. Wu et al.
NATURE COMMUNICATIONS (2016)
Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru
Brett M. Forshey et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices
Elissa Meites et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)
An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
Stefan Fernandez et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Long-Lived Plasma Cells Are Contained within the CD19-CD38hiCD138+ Subset in Human Bone Marrow
Jessica L. Halliley et al.
IMMUNITY (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal
Guilherme Goncalves et al.
VACCINE (2015)
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naive subjects
Sharon E. Frey et al.
VACCINE (2015)
Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis
Maria Paulke-Korinek et al.
VACCINE (2015)
Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions
Heidi Theeten et al.
VACCINE (2015)
Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status
Goncalo Matias et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2014)
Simultaneous Assessment of Rotavirus-Specific Memory B Cells and Serological Memory after B Cell Depletion Therapy with Rituximab
Daniel Herrera et al.
PLOS ONE (2014)
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults
Niel Hens et al.
VACCINE (2014)
How advances in immunology provide insight into improving vaccine efficacy
Mark K. Slifka et al.
VACCINE (2014)
Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: Follow-up through Month 48 in a Phase III randomized study
Mark H. Einstein et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
E. G. Kamburova et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination
Silvia Jimenez-Jorge et al.
BMC INFECTIOUS DISEASES (2013)
Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
Mahboobeh Safaeian et al.
CANCER PREVENTION RESEARCH (2013)
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Matthieu Mahevas et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Cryo-EM structure of the mature dengue virus at 3.5-angstrom resolution
Xiaokang Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure
Stephen S. H. Huang et al.
SCIENTIFIC REPORTS (2013)
Immunogenicity of protein aggregates-Concerns and realities
Wei Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
Long-lasting treatment effect of rituximab in MuSK myasthenia
J. Diaz-Manera et al.
NEUROLOGY (2012)
Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix®
Troy J. Kemp et al.
VACCINE (2012)
Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity
Y. K. Onno Teng et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Immune Response to Dengue Virus and Prospects for a Vaccine
Brian R. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2011)
Effect of rituximab on human in vivo antibody immune responses
Mark D. Pescovitz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants
Whitney E. Purtha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
Aimee R. Kreimer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial
Gerald Aichinger et al.
VACCINE (2011)
Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella
Juliana Romualdo Nascimento Silva et al.
VACCINE (2011)
Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
Ian J. Amanna et al.
IMMUNOLOGICAL REVIEWS (2010)
Antiviral Immunity following Smallpox Virus Infection: a Case-Control Study
Erika Hammarlund et al.
JOURNAL OF VIROLOGY (2010)
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
Alfred von Krempelhuber et al.
VACCINE (2010)
HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection
Mattia Bonsignori et al.
JOURNAL OF IMMUNOLOGY (2009)
The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells
Maria Mamani-Matsuda et al.
BLOOD (2008)
Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab
Alastair J. Ferraro et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Maintenance of the plasma cell pool is independent of memory B cells
Anupama Ahuja et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
B cell survival in intragraft tertiary lymphoid organs after rituximab therapy
Olivier Thaunat et al.
TRANSPLANTATION (2008)
Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice
David J. DiLillo et al.
JOURNAL OF IMMUNOLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Loss of vaccine-induced immunity to varicella over time
Sandra S. Chaves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE
Therese Vallerskog et al.
CLINICAL IMMUNOLOGY (2007)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Pharmacodynamics of rituximab in kidney allotransplantation
H. Genberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
Sandra L. Giannini et al.
VACCINE (2006)
A mathematical model to estimate global hepatitis B disease burden and vaccination impact
ST Goldstein et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)
Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease
N Yazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Influenza-associated hospitalizations in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Influenza: old and new threats
P Palese
NATURE MEDICINE (2004)
Hepatitis A booster vaccination: is there a need?
P Van Damme et al.
LANCET (2003)
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
G Cambridge et al.
ARTHRITIS AND RHEUMATISM (2003)
Structures of immature flavivirus particles
Y Zhang et al.
EMBO JOURNAL (2003)
Antigen dependent and independent mechanisms that sustain serum antibody levels
E Traggiai et al.
VACCINE (2003)
Hepatitis B vaccine - do we need boosters?
JE Banatvala et al.
JOURNAL OF VIRAL HEPATITIS (2003)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997
MS Lee et al.
VACCINE (2001)
B cells extract and present immobilized antigen: implications for affinity discrimination
FD Batista et al.
EMBO JOURNAL (2000)
Share Paper
